Beta blockers in systolic heart failure

Heart failure is a common reason for general practice encounters. It affects 4% of Australians aged 45 years or over with the prevalence increasing from about 1% at age 50-59 years to more than 50% at 84 years of age and over. Patients with heart failure are increasingly managed in the primary care...

Full description

Saved in:
Bibliographic Details
Published inAustralian family physician Vol. 37; no. 3; pp. 137 - 139
Main Authors Jackowski, Leslie, Azam, Roshmeen
Format Journal Article
LanguageEnglish
Published Australia Copyright Agency Limited (Distributor) 01.03.2008
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Heart failure is a common reason for general practice encounters. It affects 4% of Australians aged 45 years or over with the prevalence increasing from about 1% at age 50-59 years to more than 50% at 84 years of age and over. Patients with heart failure are increasingly managed in the primary care setting, and the emphasis of new national programs on early recognition of signs and diagnosis of heart failure suggest that this trend will continue. Beta blockers have been shown to reduce morbidity and mortality in patients with heart failure when used with an angiotensin converting enzyme inhibitor (ACEI) and a diuretic. (author abstract)
Bibliography:AFP.jpg
Australian Family Physician, Vol. 37, No. 3, 2008 Mar: 137-9
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0300-8495
2208-7958